Biotech giant Amgen Inc. is expected to plead guilty Tuesday to illegally marketing its drugs, sources told the New York Times.
Biotech giant Amgen Inc. is expected to plead guilty Tuesday to illegally marketing its drugs, sources told the New York Times.